Proheptazine
From Wikipedia, the free encyclopedia
|
Proheptazine
|
|
| Systematic (IUPAC) name | |
| (1,3-dimethyl-4-phenylazepan-4-yl) propanoate | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C17H25NO2 |
| Mol. mass | 275.39 g/mol |
| Synonyms | Proheptazine |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule I (US) |
| Routes | ? |
Proheptazine is an opioid analgesic from the phenazepine family. It was invented in the 1960s.[1]
Proheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
[edit] References
- ^ Diamond J, Bruce WF, Tyson FT. Synthesis and Properties of the Analgesic DL-α-1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane (Proheptazine). Journal of Medicinal Chemistry. 1964 Jan;7:57-60.

